It’s mid-May – and the IPO market is already producing remarkable results.
One American company is sitting on the world’s richest gold deposits. And production could soon hit +$160 - $200 million per year.
Today is your chance to claim IPO shares for less than $5.00.
Go here ASAP – trading starts in 60 – 90 days.
Take a look at how Initial Public Offerings are performing in 2026.
The average first-day pop across all deals is 47.6%, though the median is a more modest 14%. This tells us that the distribution is heavily skewed by a handful of outliers at the top.
And what outliers they are.
Here are the top 10 best-performing IPOs of 2026, ranked by total return from the IPO price:
· +524% with Veradermics (NASDAQ: MANE)
· +491% with Swarmer (NASDAQ: SWMR)
· +181% with The Metals Royalty Co. (NASDAQ: TMCR)
· +86% with Forgent Power Solutions (NYSE: FPS)
· +79% with SOLV Energy (NYSE: MWH)
· +70% with Avalyn Pharma (NASDAQ: AVLN)
· +68% with Cerebras Systems (NASDAQ: CBRS)
· +58% with Hemab Therapeutics (NASDAQ: COAG)
· +57% with Madison Air (NYSE: MAIR)
· +51% with Fervo Energy (NYSE: FRVO)
A few things stand out when you dig in.
The two biggest winners — Veradermics and Swarmer — were both tiny deals with no disclosed deal size. That means no institutional underwriting, no traditional roadshow, and a very small float.
My #1 IPO for 2026 is a new American gold company that looks very, very similar. I’m predicting 370% gains from the IPO price.
Shares can soar out of the gate when demand shows up for a stock with almost no shares available to trade. These returns are real, but they're not repeatable in the conventional sense.
Let’s take a look at the next tier of big winners.
Forgent Power, SOLV Energy, Madison Air, and Fervo Energy are all Industrials and Energy names. These are real businesses with institutional backing, priced in the $500 million to $2.2 billion range.
They're benefiting from durable tailwinds: AI data center buildout, the U.S. power grid, and the clean energy transition. Returns of 50% to 86% from solid, mid-size IPOs in a few months is a genuinely strong result.
Cerebras Systems stands out on the tech side. It's the largest deal on this list – raising $5.55 billion and delivering a first day gain of 68%. That's the kind of performance that gets institutional investors paying attention to the next big AI infrastructure name.
The healthcare winners — Avalyn Pharma and Hemab Therapeutics — both priced within their expected ranges and both rewarded patience. Biotech IPOs can be hit or miss. But when they work, they work.
The broader takeaway from the 2026 class so far is that sector selection matters more than most investors realize. Nearly all of the top performers were riding a powerful macro theme — clean energy, AI infrastructure, defense, or biotech innovation. Companies without that tailwind have struggled.
The next 7-months still has some major events on the calendar. SpaceX is going public within the next 45 – 60 days. Plus, Anthropic and OpenAI could be targeting a listing in late this year or next.
Want to invest in my #1 IPO for 2026? It could become America’s most profitable gold producer – going from zero to $160 million in production in the next 18-months.
That’s why I’m predicting +370% gains from the IPO price.
Ian Wyatt
Editor, IPO Watch